TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,140.81−0.59%Brent$109.22−0.54%BTC$81,930.84−0.10%ETH$2,400.75−0.27%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,140.81−0.59%Brent$109.22−0.54%BTC$81,930.84−0.10%ETH$2,400.75−0.27%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Jazz Pharmaceuticals PLC · Overview · TradingHolo

Markets › United States › NAS › JAZZ

J

Jazz Pharmaceuticals PLC

NAS:JAZZHealthcareNASDAQ:NBINASDAQ:NQUSMG

$210.23−1.95%At closeAt close · Sat 17 Oct · ≈ AED 772.07 · Market cap $13.65B · Next earnings Wed 4 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−1.9%

1M

−13.8%

3M

−13.7%

6M

+3.3%

1Y

+54.8%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

JAZZ −1.95% today

✦ This week in three lines

No written digest yet for JAZZ. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +12.5%

Valuation

P/E vs sector−38.3× vs −1.7×

Price / Book vs sector3.2× vs 2.0×

Price / Sales vs sector3.2× vs 4.0×

Price / Free cash flow vs sector11.9× vs −1.6×

cheap for itself (13.5×)expensive for itself (22.9×)

Forecasts

21 buy3 hold0 sell24 analysts

Average target$288.00 +37.0%

Analysts12

EPS surprises, last 85 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All JAZZ news →

TRSamantha Pearce to Retire as Jazz Pharmaceuticals' Chief Commercial Officer

TradingView · 10 d ago

DOJazz Pharmaceuticals Price Target Cut to $296.00/Share From $299.00 by RBC Capital

Dow Jones Newswires · 11 d ago

SENuvation, Jazz gain new Buys at Citi on oncology prospects

Seeking Alpha · 19 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$13.65B

P/E−38.3×

Dividend yield0.0%

52-week range$128.80 – $266.38

Avg volume (20d)810,510

Shares outstanding64,914,600

Beta0.32

Short interest8.8% of float

Next earningsWed 4 Nov

Radar Score

60

Value64

Quality69

Momentum62

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%